Some of its molecular targets that have been explored for cancer treatment are the effect of curcumin on cyclin-CDK complexes and CDK inhibitors as well as p53 pathway20 and MAP kinase, Wnt/β-catenin signaling pathways20. This evidence concerns the gene TP53 and cancer.